-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Apremilast in the treatment of moderate-to-severe plaque psoriasis: results from the ESTEEM studies
Jennifer C Cather, Elizabeth J Horn
Drug Evaluation: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Expanding the role of cancer prevention in clinical trials design and analysis
Graham W Warren, James R Marshall
Editorial: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
The unfolding treatment landscape for men with astration-resistant prostate cancer
Jenny J Kim, Daniel Keizman, Samuel R Denmeade,Emmanuel S Antonarakis
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation
-
New considerations in the design of clinical trials for the treatment of acute leukemia
Christopher S Hourigan, Judith E Karp
Review Article: Clinical Investigation